(Q48251845)

10 February 2018

title

Silent brain infarction and platelet activation in obstructive sleep apnea (English)

1 reference

10 February 2018

1 reference

Kenji Minoguchi

1

1 reference

10 February 2018

Takuya Yokoe

2

1 reference

10 February 2018

Toshiyuki Tazaki

3

1 reference

10 February 2018

Hideko Minoguchi

4

1 reference

10 February 2018

Naruhito Oda

5

1 reference

10 February 2018

Akihiko Tanaka

6

1 reference

10 February 2018

Mayumi Yamamoto

7

1 reference

10 February 2018

Shin Ohta

8

1 reference

10 February 2018

Christopher P O'Donnell

9

1 reference

10 February 2018

Mitsuru Adachi

10

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 March 2007

1 reference

10 February 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

10 February 2018

volume

175

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

page(s)

612-617

1 reference

10 February 2018

Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Association of sleep-disordered breathing and the occurrence of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Obstructive sleep apnea as a risk factor for stroke and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Nocturnal hypoxia is associated with silent cerebrovascular disease in a high-risk Japanese community-dwelling population

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Soluble P-selectin and the risk of future cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

The CD40/CD154 receptor/ligand dyad

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

New Markers of Inflammation and Endothelial Cell Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Elevated C-reactive protein in patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Effect of continuous positive airway pressure on soluble CD40 ligand in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Plasma adhesion molecules in children with sleep-disordered breathing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Association between lipid peroxidation and inflammation in obstructive sleep apnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

Soluble CD40 Ligand in Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200608-1141OC

10.1164/RCCM.200608-1141OC

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018